Shortage of plasma-derived products: a looming crisis?

COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications

(2021) Layal Al Mahmasani et al.   ANNALS OF HEMATOLOGY

The plasma supply in Japan

(2020) Susumu Omokawa et al.   TRANSFUSION AND APHERESIS SCIENCE

Effects of the COVID-19 pandemic on supply and use of blood for transfusion

(2020) Simon J Stanworth et al.   Lancet Haematology

Global immunoglobulin supply: steaming towards the iceberg?

(2020) Johan Prevot et al.   Current Opinion in Allergy and Clinical Immunology

The current state of the platelet supply in the US and proposed options to decrease the risk of critical shortages

(2020) James R. Stubbs et al.   TRANSFUSION

Supply and demand for plasma‐derived medicinal products – a critical re‐assessment amidst the COVID ‐19 pandemic

(2020) Jan Hartmann et al.   TRANSFUSION

Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand

(2020) A. Brand et al.   TRANSFUSION CLINIQUE ET BIOLOGIQUE

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

(2019) Anand Padmanabhan et al.   JOURNAL OF CLINICAL APHERESIS

Plasma self-sufficiency in Spain

(2019) Ll. Puig Rovira   TRANSFUSION AND APHERESIS SCIENCE

Understanding donation frequency: insights from current plasma donors

(2019) Rachel Thorpe et al.   VOX SANGUINIS

Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors

(2017) Emanuele Di Angelantonio et al.   LANCET

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

(2016) Flora Peyvandi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Plasma is a strategic resource

(2016) Paul F.W. Strengers et al.   TRANSFUSION

Essential medicines are still essential

(2015) Andy L Gray et al.   LANCET

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial

(2015) Joshua N Goldstein et al.   LANCET

Challenges in the management of the blood supply

(2013) Lorna M Williamson et al.   LANCET

Should Blood Be an Essential Medicine?

(2013) Harvey G. Klein   NEW ENGLAND JOURNAL OF MEDICINE

Plasma and plasma derivatives in therapeutic plasmapheresis

(2012) Bruce C. McLeod   TRANSFUSION

Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donations

(2010) R. Laub et al.   VOX SANGUINIS

Payment, compensation and replacement - the ethics and motivation of blood and plasma donation

(2010) A. Farrugia et al.   VOX SANGUINIS